Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
Eligible patients will be divided into two groups; one will receive neoadjuvant endocrine
therapy and the other one will receive neoadjuvant chemotherapy.